REPORT HIGHLIGHT
Surgical Site Infection Control Market size was valued at USD 3,665.5 Million in 2023, expanding at a CAGR of 5.50% from 2024 to 2032.
An infection at the surgical site is referred to as a surgical site infection. After surgery is performed on the affected body part, an infection develops. Surgical infections can range in severity from minor infections that affect the skin to major infections that affect the body's organs. When dangerous bacteria get into a cut or incision, infections grow. This is where surgery site infection management becomes necessary. Medical gadgets, protocols, and recommendations specifically developed to combat the infection can be employed. Furthermore, these infections have the potential to become fatal if not properly treated in a timely manner. The main reason for the increase in demand for surgical site infection management is the world's growing population combined with an increase in surgical operations. Globally increasing accidents have resulted in an increase in medical procedures, which has raised the need for surgical site infection management. In addition, the need for antimicrobial interventions, such as antiseptics and disinfectants, is growing because of the rise in outpatient surgical operations. These procedures do not require overnight hospital stays, and patients may become infected when they are exposed to non-healthcare environments. Therefore, taking into account the benefits of outpatient surgery, such as increased convenience and lower costs, will sustain market expansion over the projected time.
Surgical Site Infection Control Market- Market Dynamics
Growing Number of Surgical Procedures
One of the main factors propelling the growth of the surgical site infection control market is the growing number of surgical procedures performed globally. Despite breakthroughs in preventive techniques, surgical site infections (SSIs) remain among the most prevalent adverse events that occur in hospitalized patients undergoing aesthetic surgery or outpatient surgical interventions. Additionally, SSIs are the most frequent complication among patients who have undergone postoperative surgery. They are linked to high rates of mortality, considerable morbidity, and expensive strain on both individual patients and the nation's budget. Surgical site infections (SSIs) are described as infections that develop in patients up to 30 to 90 days following surgery. They impact the deeper tissues surrounding the surgical site as well as the incisional site.
Surgical Site Infection Control Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.50% over the forecast period (2024-2032)
Based on product segmentation, the surgical gloves category was predicted to show maximum market share in the year 2023
Based on surgery/procedure segmentation, the cesarean section category was predicted to show maximum market share in the year 2023
Based on type of infection segmentation, the superficial incisional SSI category was predicted to show maximum market share in the year 2023
Based on end user segmentation, the hospitals category was the leading segment in 2023
On the basis of region, North America was the leading revenue generator in 2023
Surgical Site Infection Control Market- Segmentation Analysis:
The Global Surgical Site Infection Control Market is segmented on the basis of Product, Surgery/Procedure, Type of Infection, End User, and Region.
The market is divided into the following categories based on surgery/procedure: Cataract Surgery, Cesarean Section, Dental Restoration, Gastric Bypass, and Other Surgeries/Procedures. The cesarean section category dominates the market. One of the most prevalent surgical procedures performed worldwide is the cesarean section. The number of C-section births has been gradually rising in several nations over time. Because there are so many C-sections performed, SSI prevention becomes a major area of focus for infection control initiatives. Furthermore, because the surgical site of a Cesarean section is close to the gastrointestinal and vaginal tracts, which are home to a variety of bacteria, it is especially susceptible to infection. Furthermore, there is a higher chance of infection because the treatment entails breaking down the epidermis and uterine wall's natural barriers.
The market is divided into the following categories based on type of infection: Superficial Incisional SSI, Deep Incisional SSI, and Organ or Space SSI. The superficial incisional SSI category dominates the market and is likely to maintain its dominance during the forecast period. Only the skin and subcutaneous tissue around the incision are affected by these infections, which appear 30 days after the procedure. Symptoms including redness, warmth, swelling, and localized discomfort at the surgery site are frequently present. These are some of the most typical SSIs that are seen in surgical practice. Their relative prevalence emphasizes how crucial they are to attempts to control infections. For instance, 59% of all SSI patients had superficial SSI, according to a 2023 National Library of Medicine publication.
Surgical Site Infection Control Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for Surgical Site Infection Control. Antimicrobial agents, surgical drapes, gloves, sterilizing supplies, wound care items, and monitoring systems are just a few of the many products that are part of the SSI control industry. In North American hospitals, surgical site infections (SSIs) continue to be a major concern despite improvements in surgical methods and infection control procedures. While the frequency of SSIs varies among surgical specialties and environments, they nonetheless place a significant clinical and financial strain on healthcare systems.
In addition, the Surgical Site Infection Control market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The market is expected to increase in emerging nations like China and India during the forecast period due to a number of factors, including the increasing demand for minimally invasive operations and the wide variety of uses of surgical site infection control technologies in healthcare settings. China and India are reportedly home to some of the top MedTech businesses worldwide. Healthium MedTech, an Indian medical technology business, just unveiled in October 2021 an inventive surgical wound dressing with unique infection prevention technology.
Surgical Site Infection Control Market- Competitive Landscape:
The market for surgical site infection management is characterized by fragmentation. Some major participants in the surgical site infection control market are Johnson & Johnson, Getinge Group, Biomerieux SA, Becton, Dickinson, and Company, and 3M Company. Due to the ongoing global product advancements, the competitive competition within the market under investigation has become more intense.
Recent Developments:
February 2024: Following the enrollment of its 100th patient, PolyPid Ltd., a biopharmaceutical business committed to enhancing surgical outcomes, reported significant advancements in its SHIELD II Phase 3 clinical study. The purpose of this study was to evaluate the effectiveness of D-PLEX100, a product candidate designed to reduce the risk of surgical site infections (SSIs) during surgeries involving the colorectal region.
October 2023: The veteran-owned medical solutions company Spartan Medical Inc. launched a campaign to reduce the incidence of surgical site infections (SSls) in healthcare facilities across the country and increase public awareness of the condition. Spartan Medical, Inc., a leader in the field, is always addressing the problem of SSl prevention by using a two-pronged strategy. Providing cutting-edge sterile equipment and implants alongside superior wound care solutions was the strategy involved.
April 2022: Molnlycke built a new surgical glove facility in Malaysia as part of its expansion. To ensure it can continue to meet the rising demand for Biogel gloves, the business is expanding its manufacturing capacity.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SURGICAL SITE INFECTION CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- 3M
- Becton, Dickinson and Company
- Belimed AG
- Getinge Group
- Johnson & Johnson
- Kimberly-Clark Corporation
- Sotera Health
- Ansell Limited
- Steris Corporation
- Lac-Mac Limited
- Pacon Manufacturing Corp.
- American Polyfilm Inc.
- Others
GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Manual Reprocessors Solution
- Disinfectants
- Hand Disinfectants
- Skin Disinfectants
- Surgical Scrubs
- Hair Clippers
- Surgical Drapes
- Surgical Irrigation
- Skin Preparation Solution
- Medical Nonwovens
- Surgical Gloves
- Other Products
GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGERY/PROCEDURE- MARKET ANALYSIS, 2019 - 2032
- Cataract Surgery
- Cesarean Section
- Dental Restoration
- Gastric Bypass
- Other Surgeries/Procedures
GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION- MARKET ANALYSIS, 2019 - 2032
- Superficial Incisional SSI
- Deep Incisional SSI
- Organ or Space SSI
GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Ambulatory Surgical Centers
GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA